Merck & Co., Inc.
MRK · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $65.0B | $64.2B | +1.3% |
| Operating income | $21.2B | $19.9B | +6.6% |
| Net income | $18.3B | $17.1B | +6.6% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $18.1B | $17.3B | +4.7% |
| Operating income | $5.56B | $6.75B | −17.6% |
| Net income | $5.07B | $5.79B | −12.4% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Merck's revenue in FY2025?
- $65.0B in FY2025 (Fiscal year ended Dec 31, 2025), +1.3% vs $64.2B a year earlier, per its 10-K filed Feb 2026.
- Was Merck profitable in FY2025?
- Yes: net income was $18.3B and operating income $21.2B in FY2025.
- What was Merck's revenue in Q3 2026?
- $18.1B (+4.7% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.